Distant Management of Crohn's Disease by Smartphones is Feasible and Effective Additionally it Reduces the Costs
NCT04754620 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 139
Last updated 2021-02-15
Summary
Evaluation of the feasibility, acceptability, patient satisfaction and economic benefits of smartphone video-based telehealth in the management of Crohn's disease patients
Conditions
- Crohn Disease
Interventions
- OTHER
-
real time online video visit
Participants have received an online visit by a smartphone application
Sponsors & Collaborators
-
Kocaeli University
lead OTHER
Principal Investigators
-
göktuğ şirin · Kocaeli University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-03-01
- Primary Completion
- 2020-09-01
- Completion
- 2020-09-01
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
Behavioral Therapy for Crohn's Disease
NCT06512597 ·Status: RECRUITING ·Phase: NA
-
Ciprofloxacin for the Prevention of Postoperative Endoscopic Recurrence in Crohn's Disease
NCT00609973 ·Status: COMPLETED ·Phase: PHASE2
-
Azathioprine in the Prevention of Ileal Crohn's Disease Postoperative Recurrence.
NCT02247258 ·Status: TERMINATED ·Phase: PHASE2
-
Early Immunosuppressants in Crohn's Disease
NCT00546546 ·Status: COMPLETED ·Phase: PHASE4
-
Mediterranean Diet as an add-on Therapy for Induction of Remission in Patients With Active Crohn's Disease
NCT02825316 ·Status: UNKNOWN ·Phase: NA
-
Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease
NCT01203631 ·Status: COMPLETED ·Phase: PHASE2
-
A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease
NCT02367183 ·Status: COMPLETED ·Phase: PHASE1
-
A Smartphone Application for Added Psychological Wellbeing in Crohn's Disease
NCT06221254 ·Status: RECRUITING ·Phase: NA
-
The Feasibility of Following the Crohn's Diet
NCT03691155 ·Status: COMPLETED ·Phase: NA
-
Early Bowel Resection for Terminal Ileal Crohn's Disease
NCT06116604 ·Status: RECRUITING
-
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027 ·Status: UNKNOWN
-
Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
NCT01224171 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Disease Activity and Nutrition Treat on Postoperative Recurrence and Complications After Bowel Resection for Crohn's Disease
NCT01540942 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of HMPL-004 in Subjects With Crohn's Disease
NCT00655733 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease
NCT02405442 ·Status: TERMINATED ·Phase: PHASE2
-
The Efficacy of Enteral Nutrition in Fill of the Treatment Blank Period of the Postoperative Maintain Remission Medication for Crohn's Disease (CD)
NCT01823042 ·Status: UNKNOWN ·Phase: NA
-
Telehealth Monitoring in Inflammatory Bowel Disease: Effects on Medication Compliance, Self-Efficacy, and Quality of Life
NCT06971627 ·Status: RECRUITING ·Phase: NA
-
A Study on the Impact of Online Positive Psychological Intervention on the Mental Health and Quality of Life of Crohn's Disease Patients
NCT06939712 ·Status: RECRUITING ·Phase: NA
-
Cytokines and Genes in Therapeutic Response in Crohn's Disease
NCT03266471 ·Status: COMPLETED
-
A Study to Evaluate the Impact of Care4Today® IBD, a Smart System to Facilitate the Management of Crohn's Disease by Patients and Health Care Providers
NCT04232228 ·Status: TERMINATED
-
Study to Evaluate Safety, Tolerability and Efficacy of GSK2330811 in Crohn's Disease
NCT04151225 ·Status: WITHDRAWN ·Phase: PHASE2
-
Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine
NCT00946946 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy Study of Tripterygium Glycoside Combined With Enteral Nutrition in the Treatment of Crohn's Disease for Induction Remission
NCT01820247 ·Status: UNKNOWN ·Phase: NA
-
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
NCT02976129 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Assess Whether Etrolizumab is a Safe and Efficacious Treatment for Participants With Moderately to Severely Active Crohn's Disease
NCT02394028 ·Status: COMPLETED ·Phase: PHASE3